Xolair 150 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DB26FWQMS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,547
Award facts
- Contract value 100% obligated
- $1,547.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,547.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. The award was issued on November 10, 2025, with an ultimate completion date of December 3, 2025, under a firm fixed-price contract structure with no set-aside designation. This delivery order represents a discrete procurement executed under DMS Pharmaceutical Group's broader Indefinite Delivery Contract (IDC) within the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
DMS Pharmaceutical Group was awarded a single-award IDC on November 13, 2025, under the PPV-G GEN V program with a ceiling value of $499,999,999 and a completion date of December 31, 2036. The IDC authorizes the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support Department of Defense healthcare operations globally. The PPV-G GEN V program is structured as a $30.3 billion acquisition strategy with multiple regional prime vendor contractors, positioning DMS Pharmaceutical Group as a critical supplier within the federal military medical supply chain with established performance capabilities across diverse pharmaceutical categories.
Quick answers
Who was awarded contract SPE2DB26FWQMS?
SPE2DB26FWQMS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DB26FWQMS worth?
The government has obligated $1,547 on SPE2DB26FWQMS.
Is contract SPE2DB26FWQMS an order under another contract?
Yes. SPE2DB26FWQMS is a delivery order under SPE2DB25D9307, an indefinite delivery contract.
Was contract SPE2DB26FWQMS competed?
The extent of competition for SPE2DB26FWQMS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award